The field of diabetes treatment is undergoing a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide have gained prominence as potential game-changers. This https://rishihgcy778149.estate-blog.com/37916726/upcoming-glp-1-receptor-agonists-retatrutide-and-trizepatide